ANATOMIC STAGE I BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE I BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE I BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE I BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for aggressive breast cancer hits roadblock: trial stopped early
Disease control TerminatedThis study tested two drugs, nab-paclitaxel and alpelisib, given before surgery to people with a fast-growing type of breast cancer (triple-negative) that didn't respond to standard chemo. The goal was to shrink tumors before surgery. Only 6 people took part before the study was …
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New hope for chemo-resistant breast cancer? trial tests immune-boosting drug
Disease control TerminatedThis study looked at whether the drug abemaciclib could help people with triple negative breast cancer that didn't respond to standard chemotherapy. The goal was to see if the drug could change the tumor's immune environment to make it more attackable by the body's defenses. The …
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
New program aims to boost Well-Being in young black breast cancer survivors
Symptom relief TerminatedThis study tested a program to improve quality of life for young African American women who finished treatment for early or late-stage breast cancer. About 27 women took part in either the program or a control group. The goal was to see if the program helped with physical, emotio…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 16, 2026 12:54 UTC
-
Phone support program aims to ease daily struggles for young black breast cancer patients
Symptom relief TerminatedThis study tested a program called Y-AMBIENT, designed to improve quality of life for young African American women (ages 18-44) with stage I-III breast cancer who are undergoing chemotherapy or radiation. The program included phone sessions, written materials, and videos over fou…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC
-
Can a phone app help breast cancer patients stick with lifesaving pills?
Symptom relief TerminatedThis study tested a web-based app designed to help women with early-stage hormone-positive breast cancer take their daily hormone therapy pills consistently. Many patients stop taking these pills due to side effects or lack of support, which raises the risk of cancer returning. T…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 15, 2026 19:06 UTC
-
Electric therapy for chemo nerve pain: did it work?
Symptom relief TerminatedThis study looked at whether TENS, a device that sends mild electric pulses to the skin, could help relieve nerve pain (tingling, numbness) caused by chemotherapy in people with early-stage breast cancer. Only 17 people took part before the study was stopped early. The goal was t…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Can a gut pill tame Chemo's stomach woes?
Symptom relief TerminatedThis study looked at whether rifaximin, a gut-focused antibiotic, could reduce stomach problems like pain, bloating, and diarrhea caused by pertuzumab-based chemotherapy in people with early-stage HER2-positive breast cancer. The goal was to help patients complete their cancer tr…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
New hope for breast cancer patients: drug targets hot flashes
Symptom relief TerminatedThis study tested fezolinetant, a drug that blocks a brain receptor involved in temperature control, to see if it reduces hot flashes and night sweats in breast cancer patients taking hormone therapy. Nine women with early-stage breast cancer or high risk participated. The goal w…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Jun 08, 2026 13:04 UTC
-
Gene study may explain why some breast cancers resist hormone therapy
Knowledge-focused TerminatedThis study looked at whether a specific gene mutation (HSD3B1) changes how well the hormone therapy letrozole works in postmenopausal women with early-stage, hormone-sensitive breast cancer. Researchers measured changes in tumor markers before and after treatment. The trial was e…
Matched conditions: ANATOMIC STAGE I BREAST CANCER AJCC V8
Phase: PHASE4 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC